Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Headed into 2022 with Additional Momentum for POC Testing Growth
Point-of-care pharmacy services developer Avricore Health is celebrating the successes of its pilot program to roll out testing resources at select pharmacies across Canada this year Avricore’s trademarked HealthTab platform, working with corporate partners, has provided a popular alternative to doctor clinics for getting test results related to pre-diabetes and heart disease conditions, for example The HealthTab setup, in conjunction with multinational medical devices and health care company Abbott Laboratories, is also able to screen for viruses such as SARS-CoV-2, RSV, influenza A and B, and strep Market analysts predict POC testing revenues will continue to grow through 2025 at…